Inventor · disambiguated record
Craig E. Masse
Also filed as: MASSE CRAIG · MASSE CRAIG E
72 granted patents·31 pending applications·463 citations·filing 2005–2025
99Inventor score
Files withNIMBUS LAKSHMI INC32CONCERT PHARMACEUTICALS INC14NIMBUS IRIS INC12AJAX THERAPEUTICS INC8AMGEN INC7
Top patents by PatentIndex Score
103 records- 0198US10253046B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2017·Granted Apr 9, 2019·14 cites·12 claims
- 0297US10023571B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2016·Granted Jul 17, 2018·15 cites·17 claims
- 0396US11220508B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2020·Granted Jan 11, 2022·8 cites·20 claims
- 0495US11174264B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2020·Granted Nov 16, 2021·4 cites·19 claims
- 0595US10472374B2ACC inhibitors and uses thereofGILEAD APOLLO LLC·Filed 2018·Granted Nov 12, 2019·10 cites·20 claims
- 0695US9944655B2ACC inhibitors and uses thereofGILEAD APOLLO LLC·Filed 2016·Granted Apr 17, 2018·16 cites·9 claims
- 0794US10323036B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2017·Granted Jun 18, 2019·8 cites·12 claims
- 0894US9453026B2ACC inhibitors and uses thereofGILEAD APOLLO INC·Filed 2015·Granted Sep 27, 2016·37 cites·4 claims
- 0994US8969557B2ACC inhibitors and uses thereofNIMBUS APOLLO INC·Filed 2012·Granted Mar 3, 2015·70 cites·10 claims
- 1093US10562907B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Feb 18, 2020·4 cites·26 claims
- 1193US8575221B2Derivatives of dimethylcurcuminMASSE CRAIG E·Filed 2011·Granted Nov 5, 2013·26 cites·18 claims
- 1292US11691963B26-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitorsAJAX THERAPEUTICS INC·Filed 2021·Granted Jul 4, 2023·5 cites·30 claims
- 1392US10968236B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Apr 6, 2021·3 cites·14 claims
- 1492US10196390B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2017·Granted Feb 5, 2019·10 cites·14 claims
- 1591US11046698B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2018·Granted Jun 29, 2021·6 cites·12 claims
- 1691US10793574B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Oct 6, 2020·8 cites·12 claims
- 1791US8354557B2Synthesis of deuterated morpholine derivativesCONCERT PHARMACEUTICALS INC·Filed 2009·Granted Jan 15, 2013·9 cites·8 claims
- 1891US7435823B2Compounds and methods of useAMGEN INC·Filed 2005·Granted Oct 14, 2008·19 cites·23 claims
- 1990US10577373B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Mar 3, 2020·5 cites·28 claims
- 2090US10508120B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Dec 17, 2019·5 cites·30 claims
- 2190US8704001B2Deuterated 2-amino-3-hydroxypropanoic acid derivativesMASSE CRAIG E·Filed 2009·Granted Apr 22, 2014·12 cites·17 claims
- 2289US11053241B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Jul 6, 2021·3 cites·20 claims
- 2389US10570145B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Feb 25, 2020·4 cites·26 claims
- 2489US10562906B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Feb 18, 2020·4 cites·28 claims
- 2589US9630970B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2016·Granted Apr 25, 2017·7 cites·7 claims
- 2689US9340540B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2015·Granted May 17, 2016·7 cites·20 claims
- 2789US9067948B2IRAK inhibitors and uses thereofNIMBUS IRIS INC·Filed 2013·Granted Jun 30, 2015·13 cites·10 claims
- 2888US10647713B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2017·Granted May 12, 2020·4 cites·12 claims
- 2988US9988399B2Bicyclic compounds as ACC inhibitors and uses thereofGILEAD APOLLO LLC·Filed 2014·Granted Jun 5, 2018·13 cites·21 claims
- 3086US10336752B2TYK2 inhibitors, uses, and methods for production thereofNIMBUS LAKSHMI INC·Filed 2018·Granted Jul 2, 2019·5 cites·16 claims
- 3186US10208063B2ACC inhibitors and uses thereofGILEAD APOLLO LLC·Filed 2014·Granted Feb 19, 2019·9 cites·13 claims
- 3286US9340554B2IRAK inhibitors and uses thereofNIMBUS IRIS INC·Filed 2014·Granted May 17, 2016·8 cites·9 claims
- 3386US8703941B2IRAK inhibitors and uses thereofROMERO DONNA L·Filed 2012·Granted Apr 22, 2014·13 cites·9 claims
- 3486US7943620B2Anti-anginal compoundsCONCERT PHARMACEUTICALS INC·Filed 2008·Granted May 17, 2011·8 cites·31 claims
- 3586US7872009B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Jan 18, 2011·11 cites·8 claims
- 3685US9212190B2IRAK inhibitors and uses thereofNIMBUS IRIS INC·Filed 2013·Granted Dec 15, 2015·8 cites·11 claims
- 3785US8410124B2Deuterated etravirineMASSE CRAIG E·Filed 2008·Granted Apr 2, 2013·8 cites·15 claims
- 3884US12043632B26-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitorsAJAX THERAPEUTICS INC·Filed 2021·Granted Jul 23, 2024·1 cites·35 claims
- 3984US10781204B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2018·Granted Sep 22, 2020·3 cites·8 claims
- 4084US10208044B2ACC inhibitors and uses thereofGILEAD APOLLO LLC·Filed 2014·Granted Feb 19, 2019·7 cites·13 claims
- 4184US9518065B2IRAK inhibitors and uses thereofNIMBUS IRIS INC·Filed 2014·Granted Dec 13, 2016·6 cites·14 claims
- 4283US9765089B2ACC inhibitors and uses thereofGILEAD APOLLO LLC·Filed 2014·Granted Sep 19, 2017·7 cites·3 claims
- 4383US9751892B2IRAK inhibitors and uses thereofNIMBUS IRIS INC·Filed 2015·Granted Sep 5, 2017·4 cites·23 claims
- 4482US11040967B2TYK2 inhibitors, uses, and methods for production thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Jun 22, 2021·3 cites·18 claims
- 4581US2023391797A1Tyk2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2022·Application pending·0 cites
- 4680US9175007B2IRAK inhibitors and uses thereofNIMBUS IRIS INC·Filed 2014·Granted Nov 3, 2015·4 cites·19 claims
- 4779US9145390B2Derivatives of pyrazole-substituted amino-heteroaryl compoundsCONCERT PHARMACEUTICALS INC·Filed 2013·Granted Sep 29, 2015·1 cites·12 claims
- 4879US2023056447A1Tyk2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2021·Application pending·0 cites
- 4978US2025326760A1Tyk2 inhibitors and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2025·Application pending·0 cites
- 5078US2023074228A1Tyk2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 103 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Craig E. Masse files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →